DOCSLIB.ORG

Antibody List

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Antibody List 產品編號 產品名稱 PA569955 1110059E24Rik Polyclonal Antibody PA569956 1110059E24Rik Polyclonal Antibody PA570131 1190002N15Rik Polyclonal Antibody 01-1234-42 123count eBeads Counting Beads MA512242 14.3.3 Pan Monoclonal Antibody (CG15) LFMA0074 14-3-3 beta Monoclonal Antibody (60C10) LFPA0077 14-3-3 beta Polyclonal Antibody PA137002 14-3-3 beta Polyclonal Antibody PA14647 14-3-3 beta Polyclonal Antibody PA515477 14-3-3 beta Polyclonal Antibody PA517425 14-3-3 beta Polyclonal Antibody PA522264 14-3-3 beta Polyclonal Antibody PA529689 14-3-3 beta Polyclonal Antibody MA134561 14-3-3 beta/epsilon/zeta Monoclonal Antibody (3C8) MA125492 14-3-3 beta/zeta Monoclonal Antibody (22-IID8B) MA125665 14-3-3 beta/zeta Monoclonal Antibody (4E2) 702477 14-3-3 delta/zeta Antibody (1H9L19), ABfinity Rabbit Monoclonal 711507 14-3-3 delta/zeta Antibody (1HCLC), ABfinity Rabbit Oligoclonal 702241 14-3-3 epsilon Antibody (5H10L5), ABfinity Rabbit Monoclonal 711273 14-3-3 epsilon Antibody (5HCLC), ABfinity Rabbit Oligoclonal PA517104 14-3-3 epsilon Polyclonal Antibody PA528937 14-3-3 epsilon Polyclonal Antibody PA529773 14-3-3 epsilon Polyclonal Antibody PA575298 14-3-3 eta (Lys81) Polyclonal Antibody MA524792 14-3-3 eta Monoclonal Antibody PA528113 14-3-3 eta Polyclonal Antibody PA529774 14-3-3 eta Polyclonal Antibody PA546811 14-3-3 eta Polyclonal Antibody MA116588 14-3-3 gamma Monoclonal Antibody (HS23) MA116587 14-3-3 gamma Monoclonal Antibody (KC21) PA529690 14-3-3 gamma Polyclonal Antibody PA578233 14-3-3 gamma Polyclonal Antibody 510700 14-3-3 Pan Polyclonal Antibody MA511663 14-3-3 sigma Monoclonal Antibody (1433S01) PA518462 14-3-3 sigma Polyclonal Antibody PA523507 14-3-3 sigma Polyclonal Antibody PA525884 14-3-3 sigma Polyclonal Antibody PA527147 14-3-3 sigma Polyclonal Antibody PA534644 14-3-3 sigma Polyclonal Antibody PA535219 14-3-3 sigma Polyclonal Antibody PA517426 14-3-3 theta Polyclonal Antibody PA518822 14-3-3 theta Polyclonal Antibody PA527641 14-3-3 theta Polyclonal Antibody PA529421 14-3-3 theta Polyclonal Antibody PA538397 14-3-3 theta Polyclonal Antibody MA112431 14-3-3 theta/tau Monoclonal Antibody (3B9) PA137006 14-3-3 zeta Polyclonal Antibody PA515471 14-3-3 zeta Polyclonal Antibody PA515472 14-3-3 zeta Polyclonal Antibody PA523402 14-3-3 zeta Polyclonal Antibody PA527317 14-3-3 zeta Polyclonal Antibody PA580245 14-3-3 zeta Polyclonal Antibody MA525457 15-PGDH Monoclonal Antibody (OTI2C10) MA525433 15-PGDH Monoclonal Antibody (OTI2F5) PA116666 15-PGDH Polyclonal Antibody PA19088 15-PGDH Polyclonal Antibody PA521585 15-PGDH Polyclonal Antibody PA534821 15-PGDH Polyclonal Antibody PA522889 15-PGDH Polyclonal Antibody, Biotin PA522893 15-PGDH Polyclonal Antibody, DyLight 550 PA522890 15-PGDH Polyclonal Antibody, DyLight 650 PA522892 15-PGDH Polyclonal Antibody, HRP PA565905 15-Sep Polyclonal Antibody PA569983 1700026L06Rik Polyclonal Antibody MA527880 25-OH Vitamin D3 Monoclonal Antibody (RM3) PA569002 2700060E02Rik Polyclonal Antibody PA558232 3BP5L Polyclonal Antibody PA558233 3BP5L Polyclonal Antibody 3G11 Sialoganglioside Antigen Monoclonal Antibody (eBio3G11 (SM3G11, 3G11)), eFluor 660, 50-5443-80 eBioscience 3G11 Sialoganglioside Antigen Monoclonal Antibody (eBio3G11 (SM3G11, 3G11)), eFluor 660, 50-5443-82 eBioscience MA116616 3-hydroxykynurenine Monoclonal Antibody (P3UI) PA540098 3-Methylcytosine Polyclonal Antibody MA112770 3-Nitrotyrosine Monoclonal Antibody (2A12) MA523982 4-1BB Ligand Monoclonal Antibody (282220) A16402 4-1BB Ligand Monoclonal Antibody (TKS-1), PE PA530924 4-1BB Ligand Polyclonal Antibody PA547291 4-1BB Ligand Polyclonal Antibody PA566287 4-1BB Ligand Polyclonal Antibody PA568523 4930567H17Rik Polyclonal Antibody PA569039 4933408B17Rik Polyclonal Antibody PA570030 4933434E20Rik Polyclonal Antibody A484 4-Acetamido-4'-((iodoacetyl)amino)Stilbene-2,2'-Disulfonic Acid, Disodium Salt A485 4-Acetamido-4'-Maleimidylstilbene-2,2'-Disulfonic Acid, Disodium Salt MA116590 4-aminobiphenyl DNA Monoclonal Antibody (4C11) MA515314 4E-BP1 Monoclonal Antibody (11G12C11) MA515313 4E-BP1 Monoclonal Antibody (4B6G10) AHO1382 4E-BP1 Monoclonal Antibody (554R16) MA515312 4E-BP1 Monoclonal Antibody (9E12D9) MA515005 4E-BP1 Monoclonal Antibody (E.992.6) PA511830 4E-BP1 Polyclonal Antibody PA517745 4E-BP1 Polyclonal Antibody PA520135 4E-BP1 Polyclonal Antibody PA528947 4E-BP1 Polyclonal Antibody PA530679 4E-BP1 Polyclonal Antibody PA517527 4E-BP2 Polyclonal Antibody PA557941 4E-BP2 Polyclonal Antibody PA563979 4E-BP2 Polyclonal Antibody MA520460 4E-BP3 Monoclonal Antibody (1E3) PA561027 4E-BP3 Polyclonal Antibody MA527577 4-Hydroxy-2-hexenal Monoclonal Antibody (12F4) MA527576 4-Hydroxy-2-hexenal Monoclonal Antibody (5C11.1) MA527556 4-Hydroxy-2-hexenal Monoclonal Antibody (6F10) MA527570 4-Hydroxynonenal Monoclonal Antibody (12F7) C1157 5(6)-CFDA, SE; CFSE (5-(and-6)-Carboxyfluorescein Diacetate, Succinimidyl Ester), mixed isomers C6157 5(6)-CR 6G, SE (5-(and-6)-Carboxyrhodamine 6G, Succinimidyl Ester), mixed isomers C1311 5(6)-FAM, SE (5-(and-6)-Carboxyfluorescein, Succinimidyl Ester), mixed isomers F2181 5(6)-SFX (6-(Fluorescein-5-(and-6)-Carboxamido) Hexanoic Acid, Succinimidyl Ester), mixed isomers C300 5(6)-TAMRA (5-(and-6)-Carboxytetramethylrhodamine), mixed isomers 5(6)-TAMRA-X, SE (6-(Tetramethylrhodamine-5-(and-6)-Carboxamido) Hexanoic Acid, Succinimidyl T6105 Ester), mixed isomers A1353 5-(Aminomethyl)Fluorescein, Hydrochloride MA526830 53BP1 Monoclonal Antibody (OTI2H6) PA116565 53BP1 Polyclonal Antibody PA116566 53BP1 Polyclonal Antibody PA146147 53BP1 Polyclonal Antibody PA517578 53BP1 Polyclonal Antibody PA534675 53BP1 Polyclonal Antibody PA554565 53BP1 Polyclonal Antibody PA522752 53BP1 Polyclonal Antibody, Biotin PA522757 53BP1 Polyclonal Antibody, Biotin PA522790 53BP1 Polyclonal Antibody, Biotin PA522754 53BP1 Polyclonal Antibody, DyLight 488 PA522759 53BP1 Polyclonal Antibody, DyLight 488 PA522792 53BP1 Polyclonal Antibody, DyLight 488 PA522756 53BP1 Polyclonal Antibody, DyLight 550 PA522761 53BP1 Polyclonal Antibody, DyLight 550 PA522794 53BP1 Polyclonal Antibody, DyLight 550 PA522753 53BP1 Polyclonal Antibody, DyLight 650 PA522758 53BP1 Polyclonal Antibody, DyLight 650 PA522791 53BP1 Polyclonal Antibody, DyLight 650 PA522755 53BP1 Polyclonal Antibody, HRP PA522760 53BP1 Polyclonal Antibody, HRP PA522793 53BP1 Polyclonal Antibody, HRP 703010 53BP2 Antibody (8H3L19), ABfinity Rabbit Monoclonal PA534674 53BP2 Polyclonal Antibody PA554468 53BP2 Polyclonal Antibody PA565618 53BP2 Polyclonal Antibody PA569891 5730409E04Rik Polyclonal Antibody C6127 5-CR 6G, SE (5-Carboxyrhodamine 6G, Succinimidyl Ester), single isomer D16 5-DTAF (5-(4,6-Dichlorotriazinyl) Aminofluorescein), single isomer C1359 5-FAM (5-Carboxyfluorescein), single isomer C2210 5-FAM, SE (5-Carboxyfluorescein, Succinimidyl Ester), single isomer MA523525 5-hydroxymethylcytosine Monoclonal Antibody (3I7) MA524695 5-Hydroxymethylcytosine Monoclonal Antibody (RM236) PA540097 5-hydroxymethylcytosine Polyclonal Antibody PA186851 5-Hydroxymethyluridine Polyclonal Antibody I30451 5-IAF (5-Iodoacetamidofluorescein) PA566025 5-Mar Polyclonal Antibody MA180331 5-Methylcytidine Monoclonal Antibody (33D3) MA524694 5-Methylcytosine Monoclonal Antibody (RM231) PA130675 5-Methylcytosine Polyclonal Antibody C6124 5-ROX (5-Carboxy-X-Rhodamine, Triethylammonium Salt), single isomer C6125 5-ROX, SE (5-Carboxy-X-Rhodamine, Succinimidyl Ester), single isomer F6106 5-SFX (6-(Fluorescein-5-Carboxamido) Hexanoic Acid, Succinimidyl Ester), single isomer MA524228 5T4 Monoclonal Antibody (524731) MA524229 5T4 Monoclonal Antibody (524744) PA547679 5T4 Polyclonal Antibody PA547690 5T4 Polyclonal Antibody PA567949 5T4 Polyclonal Antibody C6121 5-TAMRA (5-Carboxytetramethylrhodamine), single isomer C2211 5-TAMRA, SE (5-Carboxytetramethylrhodamine, Succinimidyl Ester), single isomer C1360 6-FAM (6-Carboxyfluorescein), single isomer C6164 6-FAM, SE (6-Carboxyfluorescein, Succinimidyl Ester), single isomer I30452 6-IAF (6-Iodoacetamidofluorescein) C6171MP 6-JOE, SE (6-Carboxy-4',5'-Dichloro-2',7'-Dimethoxyfluorescein, Succinimidyl Ester) C6156 6-ROX (6-Carboxy-X-Rhodamine), single isomer C6126 6-ROX, SE (6-Carboxy-X-Rhodamine, Succinimidyl Ester), single isomer C6123 6-TAMRA, SE (6-Carboxytetramethylrhodamine, Succinimidyl Ester), single isomer PA571467 6X-His PTPRJ Polyclonal Antibody 710286 6x-His Tag Antibody (21HCLC), ABfinity Rabbit Oligoclonal MA14806 6x-His Tag Monoclonal Antibody (13/45/31-2) R93025 6x-His Tag Monoclonal Antibody (3D5) R93125 6x-His Tag Monoclonal Antibody (3D5), HRP 372900 6x-His Tag Monoclonal Antibody (4A12E4) MA1135 6x-His Tag Monoclonal Antibody (4E3D10H2/E3) MA1135A488 6x-His Tag Monoclonal Antibody (4E3D10H2/E3), Alexa Fluor 488 MA1135A555 6x-His Tag Monoclonal Antibody (4E3D10H2/E3), Alexa Fluor 555 MA1135A647 6x-His Tag Monoclonal Antibody (4E3D10H2/E3), Alexa Fluor 647 MA1135HRP 6x-His Tag Monoclonal Antibody (4E3D10H2/E3), HRP MA181891 6x-His Tag Monoclonal Antibody (AD1.1.10), FITC MA180218 6x-His Tag Monoclonal Antibody (AD1.1.10), HRP MA121315 6x-His Tag Monoclonal Antibody (HIS.H8) MA1213151MG 6x-His Tag Monoclonal Antibody (HIS.H8) MA121315A488 6x-His Tag Monoclonal Antibody (His.H8), Alexa Fluor 488 MA121315A555 6x-His Tag Monoclonal Antibody (His.H8), Alexa Fluor 555 MA121315A647 6x-His Tag Monoclonal Antibody (His.H8), Alexa Fluor 647 MA121315BTIN 6x-His Tag Monoclonal Antibody (HIS.H8), Biotin MA121315D488 6x-His Tag Monoclonal Antibody (HIS.H8), DyLight 488 MA121315D550 6x-His Tag Monoclonal Antibody (HIS.H8), DyLight 550 MA121315D650
Load more

  1724
Copy Link
Recommended publications
  • Gene Expression Polarization
    Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression This information is current as of September 27, 2021. Fernando O. Martinez, Siamon Gordon, Massimo Locati and Alberto Mantovani J Immunol 2006; 177:7303-7311; ; doi: 10.4049/jimmunol.177.10.7303 http://www.jimmunol.org/content/177/10/7303 Downloaded from Supplementary http://www.jimmunol.org/content/suppl/2006/11/03/177.10.7303.DC1 Material http://www.jimmunol.org/ References This article cites 61 articles, 22 of which you can access for free at: http://www.jimmunol.org/content/177/10/7303.full#ref-list-1 Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision by guest on September 27, 2021 • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2006 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 Fernando O.
    [Show full text]
  • Acidic Phospholipids,47, 58 Acidification Steps, 23 Adsorbent, 53
    Index acidic phospholipids,47, 58 ATPase, 22, 107 acidification steps, 23 auto-oxidation, 48,49 adsorbent, 53 aequorin, 95 aggregated mitochondria, 23 bacterial cells, 10 alcohols, 49 bacteriorhodopsin (BR), 218,232 alkaline hydrolysis, I bee venom, 121 alkyl esters, 57, 59 binders,53 amide bond, 129 silica gel, 53, 65, 176 amide linkage, 14 silica gel H, 176 amino alcohol, II bioactive phospholipids, 144 amino-group labelling reagents, 121 blanching, 50 aminopeptidase, 17 buoyant density, 16 aminophospholipid, 113, 118 butyl hydroxy toluene (BHT), 49,212 aminophospholipid pump, 119, 140 aminophospholipid translocase, 11 3 amphotericin B (AmB), 107 Cal+ -ATPases, 28, 107 N-(1-deoxyD-fructos-1-yl) AmB, 107 Cal+ -uptake, 27 anchored lipids, 38 campesterol, 104 angular amplitude, 89 calciferol, 78 anilino-8-naphthalene sulfonate (ANS), Candida albicans, 59, 60, 61, 76, 78, 102, 94, 103 104, 108 animal cells, 10 caproic acid, 129, 130 animal tissues, 9 carotenoids, 37 anion transporter, 135 cell debris, 33 anisotropy, 81 , 89, 95, 96, 97, 102, 104, cell disintegrator, 19 105 ceramide, 14, 129, 194 antagonists, 178 ceramide monohexosides ( CMH), 60 antioxidant, 49, 50 cerebroside, 14 apolar lipids, 56, 57, 69 chemical probes,112 arachidonic acid (AA), 144,153, 161 chloroplast, 32, 33 artificial membrane, 83 isolation, 32, 33 ascending chromatography, 54 purification, 33 asymmetric topology, 128 cholesterol, 14, 15,212 asymmetry, 112, 113,119 choline, 7, 9 atebrin, 95 chromatograms, 55 Index 249 chromatographic analyses, 52 ELISA, 146, 148
    [Show full text]
  • Downloaded from GEO
    bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.252007; this version posted November 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Oxylipin metabolism is controlled by mitochondrial b-oxidation during bacterial inflammation. Mariya Misheva1, Konstantinos Kotzamanis1*, Luke C Davies1*, Victoria J Tyrrell1, Patricia R S Rodrigues1, Gloria A Benavides2, Christine Hinz1, Robert C Murphy3, Paul Kennedy4, Philip R Taylor1,5, Marcela Rosas1, Simon A Jones1, Sumukh Deshpande1, Robert Andrews1, Magdalena A Czubala1, Mark Gurney1, Maceler Aldrovandi1, Sven W Meckelmann1, Peter Ghazal1, Victor Darley-Usmar2, Daniel White1, and Valerie B O’Donnell1 1Systems Immunity Research Institute and Division of Infection and Immunity, and School of Medicine, Cardiff University, UK, 2Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA, 3Department of Pharmacology, University of Colorado Denver, Aurora, CO 80045, USA, 4Cayman Chemical 1180 E Ellsworth Rd, Ann Arbor, MI 48108, United States, 5UK Dementia Research Institute at Cardiff, Cardiff University, UK Address correspondence: Valerie O’Donnell, [email protected] or Daniel White, [email protected], Systems Immunity Research Institute, Cardiff University *Both authors contributed equally to the study 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.08.17.252007; this version posted November 3, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Bioluminescent Properties of Semi-Synthetic Obelin and Aequorin Activated by Coelenterazine Analogues with Modifications of C-2, C-6, and C-8 Substituents
    International Journal of Molecular Sciences Article Bioluminescent Properties of Semi-Synthetic Obelin and Aequorin Activated by Coelenterazine Analogues with Modifications of C-2, C-6, and C-8 Substituents 1, 2,3, 1 2, Elena V. Eremeeva y , Tianyu Jiang y , Natalia P. Malikova , Minyong Li * and Eugene S. Vysotski 1,* 1 Photobiology Laboratory, Institute of Biophysics SB RAS, Federal Research Center “Krasnoyarsk Science Center SB RAS”, Krasnoyarsk 660036, Russia; [email protected] (E.V.E.); [email protected] (N.P.M.) 2 Key Laboratory of Chemical Biology (MOE), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China; [email protected] 3 State Key Laboratory of Microbial Technology, Shandong University–Helmholtz Institute of Biotechnology, Shandong University, Qingdao 266237, China * Correspondence: [email protected] (M.L.); [email protected] (E.S.V.); Tel.: +86-531-8838-2076 (M.L.); +7-(391)-249-44-30 (E.S.V.); Fax: +86-531-8838-2076 (M.L.); +7-(391)-290-54-90 (E.S.V.) These authors contributed equally to this work. y Received: 23 June 2020; Accepted: 27 July 2020; Published: 30 July 2020 Abstract: Ca2+-regulated photoproteins responsible for bioluminescence of a variety of marine organisms are single-chain globular proteins within the inner cavity of which the oxygenated coelenterazine, 2-hydroperoxycoelenterazine, is tightly bound. Alongside with native coelenterazine, photoproteins can also use its synthetic analogues as substrates to produce flash-type bioluminescence. However, information on the effect of modifications of various groups of coelenterazine and amino acid environment of the protein active site on the bioluminescent properties of the corresponding semi-synthetic photoproteins is fragmentary and often controversial.
    [Show full text]
  • Investigation of Candidate Genes and Mechanisms Underlying Obesity
    Prashanth et al. BMC Endocrine Disorders (2021) 21:80 https://doi.org/10.1186/s12902-021-00718-5 RESEARCH ARTICLE Open Access Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules G. Prashanth1 , Basavaraj Vastrad2 , Anandkumar Tengli3 , Chanabasayya Vastrad4* and Iranna Kotturshetti5 Abstract Background: Obesity associated type 2 diabetes mellitus is a metabolic disorder ; however, the etiology of obesity associated type 2 diabetes mellitus remains largely unknown. There is an urgent need to further broaden the understanding of the molecular mechanism associated in obesity associated type 2 diabetes mellitus. Methods: To screen the differentially expressed genes (DEGs) that might play essential roles in obesity associated type 2 diabetes mellitus, the publicly available expression profiling by high throughput sequencing data (GSE143319) was downloaded and screened for DEGs. Then, Gene Ontology (GO) and REACTOME pathway enrichment analysis were performed. The protein - protein interaction network, miRNA - target genes regulatory network and TF-target gene regulatory network were constructed and analyzed for identification of hub and target genes. The hub genes were validated by receiver operating characteristic (ROC) curve analysis and RT- PCR analysis. Finally, a molecular docking study was performed on over expressed proteins to predict the target small drug molecules. Results: A total of 820 DEGs were identified between
    [Show full text]
  • Cellular and Molecular Signatures in the Disease Tissue of Early
    Cellular and Molecular Signatures in the Disease Tissue of Early Rheumatoid Arthritis Stratify Clinical Response to csDMARD-Therapy and Predict Radiographic Progression Frances Humby1,* Myles Lewis1,* Nandhini Ramamoorthi2, Jason Hackney3, Michael Barnes1, Michele Bombardieri1, Francesca Setiadi2, Stephen Kelly1, Fabiola Bene1, Maria di Cicco1, Sudeh Riahi1, Vidalba Rocher-Ros1, Nora Ng1, Ilias Lazorou1, Rebecca E. Hands1, Desiree van der Heijde4, Robert Landewé5, Annette van der Helm-van Mil4, Alberto Cauli6, Iain B. McInnes7, Christopher D. Buckley8, Ernest Choy9, Peter Taylor10, Michael J. Townsend2 & Costantino Pitzalis1 1Centre for Experimental Medicine and Rheumatology, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, UK. Departments of 2Biomarker Discovery OMNI, 3Bioinformatics and Computational Biology, Genentech Research and Early Development, South San Francisco, California 94080 USA 4Department of Rheumatology, Leiden University Medical Center, The Netherlands 5Department of Clinical Immunology & Rheumatology, Amsterdam Rheumatology & Immunology Center, Amsterdam, The Netherlands 6Rheumatology Unit, Department of Medical Sciences, Policlinico of the University of Cagliari, Cagliari, Italy 7Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow G12 8TA, UK 8Rheumatology Research Group, Institute of Inflammation and Ageing (IIA), University of Birmingham, Birmingham B15 2WB, UK 9Institute of
    [Show full text]
  • Bioluminescence Related Publications from JNC Corporation
    Bioluminescence related publications since 1985 110) Inouye, S. and Hojo, H. (2018) Revalidation of recombinant aequorin as a light emission standard: Estimation of specific activity of Gaussia luciferase. Biochem. Biophys. Res. Commun. 507: 242-245. 109) Yokawa, S., Suzuki, T., Hayashi, A., Inouye, S., Inoh, Y. and Furuno, T. (2018) Video-rate bioluminescence imaging of degranulation of mast cells attached to the extracellular matrix. Front. Cell Dev. Biol. 6: 74. 108) Inouye, S., Tomabechi, Y., Hosoya, T., Sekine, S. and Shirouzu, M. (2018) Slow luminescence kinetics of semi-synthetic aequorin:expression, purification and structure determination of cf3-aequorin. J. Biochem. 164(3): 247–255. 107) Inouye, S. (2018) Single-step purification of recombinant Gaussia luciferase from serum-containing culture medium of mammalian cells. Protein Expr. Purif. 141: 32-38. 106) Inouye, S. and Sahara-Miura, Y. (2017) A fusion protein of the synthetic IgG-binding domain and aequorin: Expression and purification from E. coli cells and its application. Protein Expr. Purif. 137: 58-63. 105) Suzuki, T., Kanamori, T. and Inouye, S. (2017) Quantitative visualization of synchronized insulin secretion from 3D-cultured cells. Biochem. Biophys. Res. Commun. 486: 886-892. 104) Yokawa, S., Suzuki, T., Inouye, S., Inoh, Y., Suzuki, R., Kanamori, T., Furuno, T. and Hirashima, N. (2017) Visualization of glucagon secretion from pancreatic α cells by bioluminescence video microscopy: Identification of secretion sites in the intercellular contact regions. Biochem. Biophys. Res. Commun. 485: 725-730. 103) Inouye, S. and Suzuki, T. (2016) Protein expression of preferred human codon-optimized Gaussia luciferase genes with an artificial open-reading frame in mammalian and bacterial cells.
    [Show full text]
  • BPS Complete Catalog
    BPSCATALOG ENZYMES KITS CELL LINES SCREENING SERVICES INNOVATIVE PRODUCTS TO FUEL YOUR EXPERIMENTS Unique, expert portfolio 2017 OUR MISSION: To provide the highest quality life science products and services worldwide in a timely manner to assist in accelerating drug discovery research and development for the treatment of human diseases. INNOVATION WE CONTINUOUSLY STRIVE TO BE FIRST TO MARKET BY PROVIDING EXPERTISE IN EXPRESSING HIGHLY ACTIVE ENZYMES MULTIPLE ASSAY DETECTION FORMATS HUMAN, MURINE AND MONKEY VERSIONS OF RECOMBINANT PROTEINS BIOTINYLATED VERSIONS OF MANY IMMUNE CHECKPOINT RECEPTORS 1ST AND MOST EXTENSIVE PARP ISOZYME PORTFOLIO 1ST AND MOST EXTENSIVE PDE ISOZYME PORTFOLIO 1ST COMPLETE SUITE OF HDAC AND SIRT ENZYMES 1ST AVAILABLE PARP AND TANKYRASE PROFILING SERVICES 1ST COMMERCIALLY AVAILABLE HISTONE DEMETHYLASES LARGEST OFFERING OF METHYLTRANSFERASES LARGEST OFFERING OF DEMETHYLASES OVER 200 PRODUCTS AND SERVICES EXCLUSIVE TO BPS RELIABILITY BPS IS CITED IN PEER-REVIEWED JOURNALS AND PUBLICATIONS AROUND THE WORLD NATURE GENETICS THE JOURNAL OF BIOLOGICAL CHEMISTRY JOURNAL OF CELL SCIENCE ANALYTICAL BIOCHEMISTRY BBRC NATURE CHEMICAL BIOLOGY ACS MEDICINAL CHEMISTRY LETTERS JOURNAL OF NATURAL PRODUCTS CHEMMEDCHEM MOLECULAR CANCER THERAPEUTICS & MANY MORE TABLE OF CONTENTS ACETYLTRANSFERASE 4 APOPTOSIS 4-5 ANTIBODIES 6-9 BIOTINYLATION 10-11 BROMODOMAINS 12-14 CELL BASED ASSAY KITS 15 CELL LINES 16-17 CELL SURFACE RECEPTORS 18-20 CYTOKINE(S) 21-24 DEACETYLASE(S) 25-27 DEMETHYLASE(S) 28-29 HEAT SHOCK PROTEINS 30 IMMUNOTHERAPY
    [Show full text]
  • UNIVERSITY of CALIFORNIA RIVERSIDE Investigations Into The
    UNIVERSITY OF CALIFORNIA RIVERSIDE Investigations into the Role of TAF1-mediated Phosphorylation in Gene Regulation A Dissertation submitted in partial satisfaction of the requirements for the degree of Doctor of Philosophy in Cell, Molecular and Developmental Biology by Brian James Gadd December 2012 Dissertation Committee: Dr. Xuan Liu, Chairperson Dr. Frank Sauer Dr. Frances M. Sladek Copyright by Brian James Gadd 2012 The Dissertation of Brian James Gadd is approved Committee Chairperson University of California, Riverside Acknowledgments I am thankful to Dr. Liu for her patience and support over the last eight years. I am deeply indebted to my committee members, Dr. Frank Sauer and Dr. Frances Sladek for the insightful comments on my research and this dissertation. Thanks goes out to CMDB, especially Dr. Bachant, Dr. Springer and Kathy Redd for their support. Thanks to all the members of the Liu lab both past and present. A very special thanks to the members of the Sauer lab, including Silvia, Stephane, David, Matt, Stephen, Ninuo, Toby, Josh, Alice, Alex and Flora. You have made all the years here fly by and made them so enjoyable. From the Sladek lab I want to thank Eugene, John, Linh and Karthi. Special thanks go out to all the friends I’ve made over the years here. Chris, Amber, Stephane and David, thank you so much for feeding me, encouraging me and keeping me sane. Thanks to the brothers for all your encouragement and prayers. To any I haven’t mentioned by name, I promise I haven’t forgotten all you’ve done for me during my graduate years.
    [Show full text]
  • Structural Capacitance in Protein Evolution and Human Diseases
    Article Structural Capacitance in Protein Evolution and Human Diseases Chen Li 1,2, Liah V.T. Clark 1, Rory Zhang 1, Benjamin T. Porebski 1,3, Julia M. McCoey 1, Natalie A. Borg 1, Geoffrey I. Webb 4, Itamar Kass 1,5, Malcolm Buckle 6, Jiangning Song 1, Adrian Woolfson 7 and Ashley M. Buckle 1 1 - Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria 3800, Australia 2 - Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich 8093, Switzerland 3 - Medical Research Council Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, CB2 0QH, UK 4 - Faculty of Information Technology, Monash University, Clayton, Victoria 3800, Australia 5 - Amai Proteins, Prof. A. D. Bergman 2B, Suite 212, Rehovot 7670504, Israel 6 - LBPA, ENS Cachan, CNRS, Université Paris-Saclay, F-94235 Cachan, France 7 - Nouscom, Baumleingasse, CH-4051 Basel, Switzerland Correspondence to Adrian Woolfson and Ashley M. Buckle: [email protected]; [email protected] https://doi.org/10.1016/j.jmb.2018.06.051 Edited by Dan Tawfik Abstract Canonical mechanisms of protein evolution include the duplication and diversification of pre-existing folds through genetic alterations that include point mutations, insertions, deletions, and copy number amplifications, as well as post-translational modifications that modify processes such as folding efficiency and cellular localization. Following a survey of the human mutation database, we have identified an additional mechanism that we term “structural capacitance,” which results in the de novo generation of microstructure in previously disordered regions. We suggest that the potential for structural capacitance confers select proteins with the capacity to evolve over rapid timescales, facilitating saltatory evolution as opposed to gradualistic canonical Darwinian mechanisms.
    [Show full text]
  • TITLE PAGE Oxidative Stress and Response to Thymidylate Synthase
    Downloaded from molpharm.aspetjournals.org at ASPET Journals on October 2, 2021 -Targeted -Targeted 1 , University of of , University SC K.W.B., South Columbia, (U.O., Carolina, This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted.
    [Show full text]